Yuyu Pharma, Inc. (KRX:000220)

South Korea · Delayed Price · Currency is KRW

4,130.00

+45.00 (1.10%)

Apr 8, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Mar '17 Mar 31, 2017
Pharmaceuticals			-	138.88B	115.66B	-	-
Pharmaceuticals Growth			-	20.08%	-	-	-
Total			-	138.88B	115.66B	-	-
Total Growth			-	20.08%	-	-	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Mar '17 Mar 31, 2017
South Korea			136.70B	137.84B	114.56B	97.55B	90.05B
South Korea Growth			-0.82%	20.32%	17.43%	8.33%	8.82%
Overseas			510.01M	1.04B	1.09B	565.75M	824.79M
Overseas Growth			-51.18%	-4.44%	93.23%	-31.41%	140.88%
Total			137.21B	138.88B	115.66B	98.12B	90.88B
Total Growth			-1.20%	20.08%	17.87%	7.97%	9.36%

Source: S&P Global Market Intelligence.